Catalent to sell New Jersey drug facility to Ardena
Dive Brief: Ardena, a Belgium-based pharmaceutical contract manufacturer, will acquire Catalent’s facility in Somerset, New Jersey, according to an Oct. 14 press release. Ardena will leverage the oral drug products facility, which has 200 employees, to …